Candriam S.C.A. Legend Biotech Corp Call Options Transaction History
Candriam S.C.A.
- $17.1 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding LEGN
# of Institutions
225Shares Held
74.3MCall Options Held
279KPut Options Held
350K-
Price T Rowe Associates Inc Baltimore, MD11.2MShares$426 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.51MShares$287 Million5.1% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.64MShares$253 Million7.41% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$218 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.04MShares$192 Million1.16% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $6.39B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...